The Application of Nuclear Medicine

  • Giner Maslebu Faculty of Science and Mathematics, Universitas Kristen Satya Wacana
  • Suryasatriya Trihandaru Faculty of Science and Mathematics, Universitas Kristen Satya Wacana
Keywords: nuclear medicine, biomolecules, analytes, nanotechnology, neutron application


Currently, the practice of nuclear medicine in modern countries comprises a large number of procedures. It is applied to study function of organs/body systems, to visualize, to characterize, and to quantify the functional state of lesions and for targeted radionuclide therapy. This overview presents all kinds of application in nuclear medicine services. Instrumentation and radioactive/radiolabeled substances are the basic components for application. Biotechnology contributes to the development and production of biomolecules used in radiopharmaceuticals. As a diagnostic modality, imaging depicts radioactivity distribution as a function of time. Hybrid imaging provides more precise localization and definition of le-sions as well as molecular imaging cross validation. Counting tests study invivo
organ functions externally or assess analytes in the biologic samples. Radiopharmaceutical therapy can be applied directly into the lesion or targeted systemically. Nanotechnology facilitates targeting and opens the development of bimodal techniques. In addition, neutron application contributes to the advancement of nuclear medicine services, such as neutron activation analysis, neutron teletherapy and neutron capture therapy.


Download data is not yet available.


Feinendegen LE. 1992. Nuclear medicine: a general overview and current trend. In 5th AOCNMB Jakarta-Bali, 25-30 October

Tammat SR. 2006. Kimia Radiopharmaka. Workshop nasional preparasi dan aplikasi radiofarmaka. Pusat radioisotop dan radiofarmaka, BATAN

Hong H, Zhang Y, Sun J, et al. 2009. Molecular imaging and therapy of cancer with radiolabeled nanoparticles. NanoToday;4:399-413

Pranoto S. 2015. Aplikasi kedokteran nuklir. Salatiga: SupraMedika,Ed 3.

Wheat JM, Currie GM, Davidson R, et al. 2011. Radionuclide therapy. Radiographer; 58(9):53-61

Liu S. 2004. The role of coordination chemistry in the development of targetspecific radiopharmaceuticals. Chem Soc Rev;33:445-461

Ersahin D, Doddamane I, Cheng D. 2011. Targeted radionuclide therapy. Cancer;3: 3838-3855

Ting G, Chang C-H, Wang H-E, et al. 2010. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J Biomed Biotechnol:17pp

Morales-Avila E, Ferro-Flores G, OcampoGarcia BE, et al. 2013. Radiolabeled nanoparticles for molecular imaging. http://[10-desember-2013]

Misri R, Meier D, Yung AC, et al. 2012. Development and valuation of a dualmodality (SPECT/MRI) molecular imaging bioprobe. Nanomedicine:nanotechnol, biol and med; 8:1007-1016

Soenarjo S. 2008. Analisis pengaktipan neutron. J Rad Far;11:37-53

Floberg J. 2005. The physics of boron neutron capture therapy: an emerging and in-novative treatment for glioblastoma and melanoma.
How to Cite
Maslebu, G., & Trihandaru, S. (2016). The Application of Nuclear Medicine. Indonesian Journal of Physics and Nuclear Applications, 1(2), 81-84.